Understanding how DNA amplification affects diseases like cancer and cardiac disorders
Deciphering Networks Controlling DNA Amplification
This study is looking into how certain pieces of DNA can multiply in our cells and how this might affect conditions like cancer and heart disease, with the goal of finding ways to better manage these changes and improve treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst of Fox Chase Can Ctr NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10977064 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind DNA amplification, particularly focusing on transient extrachromosomal DNA (ecDNA) and its role in diseases such as cancer and cardiac disorders. The study aims to identify specific enzymes and chromatin factors that regulate these DNA copy gains, which can lead to variations in gene expression and treatment responses. By understanding these processes, the research seeks to develop strategies to control DNA amplification events, potentially improving therapeutic outcomes for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with cancer or cardiac disorders who may be affected by DNA amplification.
Not a fit: Patients with conditions unrelated to DNA amplification or those not diagnosed with cancer or cardiac diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that improve treatment responses for patients with cancer and cardiac diseases.
How similar studies have performed: Previous research has shown promising results in understanding DNA amplification mechanisms, indicating potential for success in this area.
Where this research is happening
Philadelphia, United States
- Research Inst of Fox Chase Can Ctr — Philadelphia, United States (Active)
Researchers
- Principal investigator: Whetstine, Johnathan R. — Research Inst of Fox Chase Can Ctr
- Study coordinator: Whetstine, Johnathan R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.